Cherkas, Andriy; Holota, Serhii; Mdzinarashvili, Tamaz; Gabbianelli, Rosita; Žarković, Neven
(2020)
Glucose as a Major Antioxidant: When, What for and Why It Fails?.
Antioxidants, 9
(2).
ISSN 2076-3921
Abstract
A human organism depends on stable glucose blood levels in order to maintain its metabolic needs. Glucose is considered to be the most important energy source, and glycolysis is postulated as a backbone pathway. However, when the glucose supply is limited, ketone bodies and amino acids can be used to produce enough ATP. In contrast, for the functioning of the pentose phosphate pathway (PPP) glucose is essential and cannot be substituted by other metabolites. The PPP generates and maintains the levels of nicotinamide adenine dinucleotide phosphate (NADPH) needed for the reduction in oxidized glutathione and protein thiols, the synthesis of lipids and DNA as well as for xenobiotic detoxification, regulatory redox signaling and counteracting infections. The flux of glucose into a PPP—particularly under extreme oxidative and toxic challenges—is critical for survival, whereas the glycolytic pathway is primarily activated when glucose is abundant, and there is lack of NADP+ that is required for the activation of glucose-6 phosphate dehydrogenase. An important role of glycogen stores in resistance to oxidative challenges is discussed. Current evidences explain the disruptive metabolic effects and detrimental health consequences of chronic nutritional carbohydrate overload, and provide new insights into the positive metabolic effects of intermittent fasting, caloric restriction, exercise, and ketogenic diet through modulation of redox homeostasis.
Item Type: |
Article
|
Additional Information: |
A.C. received Georg Forster (HERMES) Scholarship from Alexander von Humboldt Foundation (Bonn, Germany). This article/publication is based upon work from COST Action NutRedOx-CA16112 "Personalized Nutrition in aging society: redox control of major age-related diseases" supported by COST (European Cooperation in Science and Technology). AC is a participant in Hypo-RESOLVE (Hypoglycaemia-REdefining SOLutions for better liVEs), a project in the framework of Innovative Medicines Initiative (IMI) funded by European Commission and European Federation of Pharmaceutical Industries and Associations. |
Uncontrolled Keywords: |
glucose ; pentose phosphate pathway ; NADPH ; redox balance ; glycogen ; glycolysis ; stress resistance ; insulin resistance |
Subjects: |
BIOMEDICINE AND HEALTHCARE > Basic Medical Sciences |
Divisions: |
Division of Molecular Medicine |
Depositing User: |
Tea Vuković
|
Date Deposited: |
04 May 2020 06:14 |
URI: |
http://fulir.irb.hr/id/eprint/5685 |
DOI: |
10.3390/antiox9020140 |
Actions (login required)
|
View Item |
5685
WOS:000519877100067